Big Move For Tetraphase Pharmaceuticals, Inc.
Wed, Jan 22, 2020 at 05:30 PM
Tetraphase Pharmaceuticals, Inc. (TTPH:NASDAQ) rocketted at $3.84, a gain of 29.7%. On Tue 21 Jan 20, TTPH:NASDAQ touched a New 2-Week Intraday High of $3.07. From Mon 30 Dec 19, the stock recorded 57.14% Up Days and 46.67% Green Days
The stock spiked on Fri 27 Dec 19 at $4.3 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About Tetraphase Pharmaceuticals, Inc. (TTPH:NASDAQ)
Tetraphase Pharmaceuticals Inc is a clinical stage biopharmaceutical company engaged in creating novel antibiotics for serious and life-threatening multidrug-resistant infections.
Top 10 Gainers:
- Genprex, Inc. (GNPX:NASDAQ), 64.35%
- Concert Pharmaceuticals, Inc. (CNCE:NASDAQ), 33.03%
- Tetraphase Pharmaceuticals, Inc. (TTPH:NASDAQ), 29.73%
- Genius Brands International, Inc. (GNUS:NASDAQ), 27.12%
- One Stop Systems, Inc. (OSS:NASDAQ), 25.85%
- Inuvo, Inc. (INUV:NYSEMKT), 23.28%
- Baudax Bio, Inc. (BXRX:NASDAQ), 21.16%
- Express, Inc. (EXPR:NYSE), 20.72%
- AgEagle Aerial Systems, Inc. (UAVS:NYSEMKT), 20.2%
- Applied Genetic Technologies Corporation (AGTC:NASDAQ), 19.52%